Latest updates and new developments (45 minutes)
- Evolving role of SGLT2 inhibitors in HF
- Initiating ARNI in hospitalized patients with decompensated HF
- Emerging therapies and potential place in HF management
Attendee questions answered by the experts (15 minutes)
Date / Time
The goal of this program is to improve the knowledge and competence of cardiologists, internists, hospitalists, and other clinicians on new and emerging treatment strategies to reduce HF-related hospitalization and death.
This activity is intended for cardiologists, hospitalists, internists, and other healthcare providers who treat patients with heart failure.
Upon completion of this activity, participants should be able to:
- Summarize new data from PIONEER-HF regarding timing of initiation of ARNI patients who have experienced acute decompensated HF
- Describe the expected benefits on SGLT2 inhibitors in patients with HF
- Summarize clinical trial data regarding investigational treatments for patients with HFrEF
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.